A new class of drugs that fight migraines could cost as much as $10,000 a year, NBC News reports. » Read More
The death rate from drug overdoses more than doubled between 1999 and 2015, according to a report from the CDC. » Read More
By: Lauren Thomas
Shares of Incyte rose more than 6 percent in Friday trade on news that the pharmaceutical company will join the S&P 500. » Read More
By: Ali Vitali
Vice President Mike Pence issued a proclamation to the Conservative Political Action Conference Thursday: the "Obamacare nightmare is about to end." » Read More
The deal could include $8.5 billion in cash as well as future royalty payments for the embattled pharmaceutical company.
The Republican presidential nominee is hoping that stories about rising Obamacare rates will help him with voters next Tuesday.
Billionaire investor and Hillary Clinton-supporter Mark Cuban said that Donald Trump has no idea how Obamacare works.
Health care advocates are urging people to shop for 2017 coverage when the annual open enrollment period begins.
Valeant's former CEO and CFO are at the center of a U.S. criminal probe against the drugmaker over its ties to a specialty pharmacy.
Enrollment runs from Tuesday through Jan. 31. Most Americans must have some form of health coverage during 2017 or face a tax penalty.
The IBB fell nearly 11 percent this month and could be headed lower.
U.S. hospital staffing provider TeamHealth said on Monday it agreed to be acquired by Blackstone in a deal valued at about $6.1 billion.
Half of the people who buy health plans through government-run Obamacare marketplaces are cutting back on care to manage costs.
Last year the flu cost the economy billions of dollars. This season could be worse, since fewer people are opting for vaccinations.
The deal requires Mylan to pay $465 million to settle claims the company shortchange Medicaid on EpiPen rebates.
Most voters care more about issues other than health care when it comes to picking the next president.
Average deductibles for Obamacare bronze plans will top $6,000 for individuals for the first time next year.
Auvi-Q's return was announced as Mylan continues to be criticized for raising the price of lifesaving EpiPens more than 500 percent in recent years.
Median incomes have not kept pace with the inflation rate for job-based health insurance costs, straining family budgets.
For many, Theranos and Elizabeth Holmes represented a promise that disease could be caught sooner, NBC News reports.
Financial advisors warn that near-certain high medical costs should be a key line item in any investor's retirement plan.
Top-ranked analyst Irina Koffler of Mizuho Securities initiated shares of Mylan with a buy rating on Wednesday.
Donald Trump has said in the past his workers get health coverage from their jobs, and this means they wouldn't have to buy Obamacare plans.
Mylan has raised prices of the anti-allergy device more than 500 percent in recent years.
Get the best of CNBC in your inbox